September 24, 2020
For the seventh consecutive year, Cancer Treatment Centers of America® (CTCA) Chicago has been recognized as a top center in the country for providing quality breast cancer care by the National Quality Measures for Breast Centers (NQMBC®) program....
Read MoreSeptember 02, 2020
CareATC, a leader in workforce population health management, has signed an agreement with Cancer Treatment Centers of America (CTCA), making CTCA® its preferred oncology care provider. Effective Tuesday, September 1, 2020, many CareATC clients can...
Read MoreMay 21, 2020
The COVID-19 pandemic has caused disruption in oncology care and is creating a cancer “shadow curve” that may result in a dramatic spike in undiagnosed and untreated cancer cases as a side-effect of the pandemic. The US has already witnessed a 37...
Read MoreMarch 15, 2020
Cancer Treatment Centers of America® (CTCA) Chicago has signed an agreement with Aetna, making it a contracted oncology care provider. Effective March 15, 2020, many Aetna commercial members can now select CTCA® Chicago and both Illinois Outpatient...
Read MoreFebruary 12, 2020
Cancer Treatment Centers of America® (CTCA) recently announced that its hospitals located in Chicago, Philadelphia and Tulsa have been named “Top Patient-Recommended Hospitals” in the nation, as reported by Becker's Hospital Review.
Read MoreFebruary 06, 2020
Cancer Treatment Centers of America Atlanta has named Jonathan Watkins, MPA, FACHE, regional president, CTCA Hospitals and Clinics.
Read MoreFebruary 06, 2020
Cancer Treatment Centers of America hospitals in Chicago, Philadelphia and Tulsa were named among the top patient-recommended hospitals in the country, according to the most recent HCAHPS scores.
Read MoreJanuary 30, 2020
For the second year in a row, Cancer Treatment Centers of America® (CTCA) Chicago (Previously known as Cancer Treatment Centers of America at Midwestern Regional Medical Center) is pleased to announce it has received a five-star quality rating from...
Read MoreJanuary 29, 2020
Cancer Treatment Centers of America® (CTCA) has released its seventh annual summary of Patient Treatment Results, a comprehensive presentation of treatment outcomes including length of life, quality of life, the patient experience, and patient...
Read MoreDecember 05, 2019
Investigational medicine NKTR-255 being evaluated for safety and tolerability as monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma or multiple myeloma and in combination with multiple targeted antibodies in multiple myeloma
Read More
Donate to Breast Cancer Research
...and University of Phoenix will match your donation through the month of October!
Gateway for Cancer Research is a 501(c)(3) non-profit organization. Charitable ID #: 73-1386920